LAURUS GENERICS INC
PharmaLAURUS GENERICS INC is a pharmaceutical company focused on Infectious Disease.
LAURUS GENERICS INC's Key Drugs
LAURUS GENERICS INC's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
LAURUS GENERICS INC's Recent FDA Approvals
New NDA/BLA approvals for LAURUS GENERICS INC over the last two years — novel drugs only, excluding generics and label supplements.
LAURUS GENERICS INC's Therapeutic Areas
LAURUS GENERICS INC's approved drugs and pipeline span 1 therapeutic area, led by Infectious Disease. Weighted by commercial stage — approved drugs count most, then late-stage trials.
LAURUS GENERICS INC's Top Competitors
LAURUS GENERICS INC's closest competitors by therapeutic-area and drug-target overlap include Pfizer, Merck, and Baxter. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
LAURUS GENERICS INC Pipeline Snapshot
Active clinical trials for LAURUS GENERICS INC across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Infectious Disease pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- -
- Latest
- -
- Applications
- 2